GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

10 Mar 2010 07:00

RNS Number : 2903I
ViaLogy PLC
10 March 2010
 



VIALOGY PLC ("VIALOGY")

VIALOGY SIGNS RENEWABLE ENERGY CONTRACT WITH ENEL NORTH AMERICA TO CHARACTERIZE AND DE-RISK GEOTHERMAL PROSPECTS

n ViaLogy technology extended to green energy

n Goal is reduction of exploration/drilling risks/costs

 

London, March 10. ViaLogy (LSE:VIY) announces signing of a contract with Enel North America, a subsidiary of Enel Green Power, the Enel Group company operating renewable energy sources in 14 countries, including the US. Enel Green Power is one of the world's leading players in the renewables industry and a global leader in geothermal power generation. The Enel Group is Italy's largest power company and Europe's second listed utility by installed capacity.

Under its initial contract, ViaLogy will extend its QuantumRD sub-surface detection technology to seismic survey design, and the identification and location of appropriate geothermal drilling locations at an Enel North America site in Nevada.

Geothermal energy generation obliges commitment of very large capital resources, and a determining factor in the geothermal business equation is the inordinately high cost of exploration, drilling and extraction which entails significant risk. Geothermal well positioning requires robust detection and characterization of natural cracks and fractures in volcanic regions with extremely hard rock; accurate mapping of fractures and discontinuities forming pressurized traps; and mapping formations that can support drilling holes with large diameters in hard rock.

QuantumRD's ability to assess complex subsurface stratigraphy, porosity and fluid saturation levels more accurately than other current technologies, utilizing seismic, magneto-telluric and other chemical tracer data, should reduce risk and alter the sector's investment risk profile. Over time, this could contribute to the broader use of clean, environmentally sustainable geothermal-based electricity.

ViaLogy's Energy business focus remains squarely on the upstream hydrocarbon industry sector where its QuantumRD technology is projected to build upon its success thus far to become an industry standard. But the opportunity to bring its technology to bear in such a vital and financially promising part of the green energy industry is important to the company's future success and earnings, as well as an opportunity to do its part in mitigating the effects of global warming.

ViaLogy CEO, Robert W. Dean, said, "The Enel contract opens up a new market for us in renewable energy development. It broadens our business base, and provides yet another means of developing and refining our QuantumRD technology, and could be a significant source of 'green' growth."

 

 

For further information please contact

ViaLogy plc

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756)

 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley +44 (0) 20-7107-8000

 

 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com. Except for statements of historical fact, the information presented herein constitutes forwardlooking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results.

 

About Enel Green Power and Enel North America

Enel Green Power is the renewable power company of Enel S.p.A. aimed at developing and operating power generation from renewable sources in Italy and around the world. The company's business incorporates all of Enel's activities in the wind, solar, geothermal, hydroelectric and biomass fields in Europe, North America and Central and South America. With over 4,500 MW of installed capacity and 17.2 TWh of produced electricity in 2008, Enel Green Power is a leading global company in renewables. Enel North America, Inc. is a subsidiary of Enel Green Power and operates all EGP renewable energy plants in 20 U.S. States and in three Canadian Provinces. For further information, please visit http://enelgreenpower.com/en/.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSSDFSUFSSEED
Date   Source Headline
7th Feb 20177:00 amRNSSouthern Europe Business Update
10th Jan 20173:33 pmRNSResult of General Meeting
10th Jan 20177:15 amRNSHardman Research: Yourgene improves growth
21st Dec 20164:00 pmRNSPosting of Circular
21st Dec 20167:00 amRNSHalf year results
21st Dec 20167:00 amRNSConditional Acquisition of Yourgene Bioscience
21st Nov 20167:00 amRNSPremaitha establishes first service lab in Asia
31st Oct 20167:00 amRNSPremaitha welcomes UK Govt. decision on NIPT
27th Oct 20164:10 pmRNSResult of AGM
27th Oct 20167:00 amRNSAGM Statement
21st Oct 20167:00 amRNSGrant of Options
3rd Oct 20167:15 amRNSHardman Research: Excellent first year for IONA®
30th Sep 20163:38 pmRNSNotice of AGM
30th Sep 20167:00 amRNSFinal Results
23rd Sep 201610:42 amRNSHolding(s) in Company
23rd Sep 20168:50 amRNSNotice of results & appointment of broker
23rd Sep 20168:50 amRNSInvestment agreement extension with Thermo Fisher
8th Sep 20169:08 amRNSDirectorate Change
6th Jul 20167:00 amRNSDirectorate Change
4th Jul 20167:00 amRNSProgress on anti-trust objections to litigation
22nd Jun 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
22nd Apr 201610:45 amRNSUpdate on competitor patent litigation
20th Apr 201611:14 amRNSHardman Research: IONA sales & litigation update
20th Apr 20167:00 amRNSPatent Litigation Rescheduled
18th Apr 20161:13 pmRNSHardman & Co Issues Research Report
18th Apr 20161:03 pmRNSHardman & Co Issues Research Report
14th Apr 20167:00 amRNSHolding(s) in Company
13th Apr 20169:52 amRNSHolding(s) in Company
13th Apr 20167:00 amRNSHoldings in Company, Director's Shareholding
11th Apr 20167:00 amRNSTrading Update
29th Mar 20167:00 amRNSPremaitha announces tenth customer laboratory
21st Mar 20167:00 amRNSDistribution Agreements in the Middle East
9th Mar 20165:21 pmRNSHolding in Company, Directors' Dealing Replacement
9th Mar 20163:33 pmRNSHolding in Company, Directors' Dealings
9th Mar 20167:00 amRNSDistribution Agreement with GeNext - Russia
7th Mar 20167:00 amRNSAppointment of Joint Broker
3rd Feb 20167:00 amRNSPremaitha partners with Visional Medical in India
2nd Feb 20167:00 amRNSPremaitha partners with Leeds Hospitals NHS Trust
28th Jan 20167:00 amRNSHardman & Co Research Report: IONA®-Up and running
27th Jan 20167:00 amRNSTwo new customers signed for clinical lab service
26th Jan 20162:29 pmRNSUpdate on UK Litigation Timing
15th Jan 20167:00 amRNSPremaitha welcomes NSC recommendation on NIPT
8th Jan 201612:40 pmRNSUpdate on competitor patent litigation
18th Dec 20157:00 amRNSDirector/PDMR Shareholding
16th Dec 20155:53 pmRNSHolding(s) in Company
15th Dec 20157:00 amRNSHardman Issues Research Report
14th Dec 20157:00 amRNSInvestment Agreement with Thermo Fisher Scientific
14th Dec 20157:00 amRNSHalf Yearly Report
11th Dec 20157:00 amRNSNotice of Half Year Results
2nd Dec 20157:00 amRNSFirst IONA® testing service in France at LaboSud

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.